CHI3L1 and Alzheimer disease: Compared to neurological controls, increased YKL-40 levels were detected in sCJD and Alzheimer's disease (AD) but not in vascular dementia (VaD) or in dementia with Lewy bodies (DLB)/Parkinson's disease dementia (PDD).